Evidence mapPaperPMID 35369082Full record

ReviewFrontiers in nutrition2022

Potential Role of Ginger (

Raúl Arcusa, Débora Villaño, Javier Marhuenda, Miguel Cano, Begoña Cerdà, Pilar Zafrilla

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
27.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Assessment of Aflatoxins and Heavy Metals inFoods (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Raúl ArcusaDepartment of Pharmacy, Faculty of Health Sciences, Catholic University of San Antonio (UCAM), Murcia, Spain.
Débora VillañoDepartment of Pharmacy, Faculty of Health Sciences, Catholic University of San Antonio (UCAM), Murcia, Spain.
Javier MarhuendaDepartment of Pharmacy, Faculty of Health Sciences, Catholic University of San Antonio (UCAM), Murcia, Spain.
Miguel CanoDepartment of Pharmacy, Faculty of Health Sciences, Catholic University of San Antonio (UCAM), Murcia, Spain.
Begoña CerdàDepartment of Pharmacy, Faculty of Health Sciences, Catholic University of San Antonio (UCAM), Murcia, Spain.
Pilar ZafrillaDepartment of Pharmacy, Faculty of Health Sciences, Catholic University of San Antonio (UCAM), Murcia, Spain.
Universidad Católica San Antonio de Murcia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginger is composed of multiple bioactive compounds, including 6-gingerol, 6-shogaol, 10-gingerol, gingerdiones, gingerdiols, paradols, 6-dehydrogingerols, 5-acetoxy-6-gingerol, 3,5-diacetoxy-6-gingerdiol, and 12-gingerol, that contribute to its recognized biological activities. Among them, the major active compounds are 6-shogaol and 6-gingerol. Scientific evidence supports the beneficial properties of ginger, including antioxidant and anti-inflammatory capacities and in contrast, a specific and less studied bioactivity is the possible neuroprotective effect. The increase in life expectancy has raised the incidence of neurodegenerative diseases (NDs), which present common neuropathological features as increased oxidative stress, neuroinflammation and protein misfolding. The structure-activity relationships of ginger phytochemicals show that ginger can be a candidate to treat NDs by targeting different ligand sites. Its bioactive compounds may improve neurological symptoms and pathological conditions by modulating cell death or cell survival signaling molecules. The cognitive enhancing effects of ginger might be partly explained

Indexed as

Alzheimer's diseaseantioxidantsgingergingerolmultiple sclerosisneurodegenerative diseasesParkinson's disease

Identifiers

PMID35369082
PMCPMC8971783
OpenAlexW4220694604

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.